Signaling Pathways
-
A8607 PPY ATarget: Abl kinasesSummary: Abl kinases inhibitor
-
A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R inhibitor
-
A8661 MNSSummary: Inhibitor of Src/Syk tyrosine kinases
-
A8683 NVP-BHG712Target: Eph Receptors|VEGFRSummary: EphB4 inhibitor,potent and selective
-
A8684 ZM 306416Summary: VEGFR (Flt and KDR) inhibitor
-
A8691 Flumatinib mesylateSummary: PDGRFβ inhibitor
-
A8692 PF-431396Summary: Pyk2 and FAK inhibitor
-
A8812 PD173955Target: Bcr-Abl|SrcSummary: Dual Src/Abl kinase inhibitor, ATP-competitive,
-
B1305 SKLB1002Summary: VEGFR2 inhibitor,potent and ATP-competitve
-
B1402 GZD824Target: Bcr-AblSummary: Bcr-Abl inhibitor,novel orally bioavailable